<DOC>
	<DOCNO>NCT01505998</DOCNO>
	<brief_summary>The purpose study single dose bioequivalence Amlodipine Besylate/Benazepril HCl 10 mg/40 mg capsule Lotrel® capsule healthy human subject monitor clinical status , adverse event laboratory investigation assess relative safety tolerance fed condition .</brief_summary>
	<brief_title>Bioequivalence Study Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules Dr. Reddy 's Under Fed Conditions</brief_title>
	<detailed_description>An open-label randomized , single dose , two way crossover oral bioequivalence study compare Amlodipine Besylate/Benazepril Hydrochloride 10 mg/40 mg capsule ( Dr. Reddy 's Laboratories Ltd. , ) Lotrel® capsule Novartis Pharmaceuticals Corporation healthy human subject feed condition .</detailed_description>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Subjects provide write informed consent . Subjects must healthy adult within 1845 year age ( inclusive ) . Body mass index ≥18 kg/m2 ≤25 kg/m2 , body weight less 50 kg . Subjects must normal health determine medical history physical examination perform within 15 day prior dose period I . Have normal ECG , Chest Xray vital sign . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . If subject female volunteer child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . postmenopausal least 1 year . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) •Each female subject give urine pregnancy test checkin periodI , periodII post study . Subjects incapable understanding informed consent . Subjects BP ≤90/60 mm/Hg BP ≥140/90 mm/Hg History hypersensitivity idiosyncratic reaction Amlodipine Besylate/Benazepril Hydrochloride related drug . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . Subjects history tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study Regular smoker smoke ten cigarette daily difficulty abstain smoke duration study period . Subjects take counter prescribed medication , include enzyme modifying drug systemic medication within past 30 day prior dose PeriodI . History psychiatric illness , may impair ability provide write , informed consent . Subjects history alcohol substance abuse within last 5 year Subjects clinically significant abnormal value laboratory parameter . Subjects participate clinical investigation use experimental drug bleed 350 mL past 3 month . Subjects unable likely noncompliant protocol requirement restriction . Any subject Amlodipine Besylate /Benazepril Hydrochloride contraindicate medical reason Subjects intolerant venipuncture Subjects positive urine screen drug abuse . All subject urine sample assay presence drug abuse part clinical laboratory screening procedure study period checkin . Subjects found urine concentration test drug allow participate Female volunteer use implant injected hormonal contraceptive anytime 6 month prior study use hormonal contraceptive within 14 day dose Female volunteer demonstrate positive pregnancy screen . All female subject screen pregnancy checkin study period . Subjects positive inconclusive result withdraw study Female volunteer currently breast feed . Female subject pregnant , breastfeeding , likely become pregnant study allow participate . Female subject child bear potential must either abstain sexual intercourse use reliable barrier method ( e.g . condom , IUD ) contraception course study ( first dose last blood collection ) allow participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>